{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:16:07Z","timestamp":1780632967310,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1124\/dmd.111.040006","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T02:22:42Z","timestamp":1310696562000},"page":"1866-1872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms"],"prefix":"10.1016","volume":"39","author":[{"given":"Zhen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.040006_bib1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1124\/dmd.111.040006_bib2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1124\/dmd.107.019943","article-title":"Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers","volume":"36","author":"Brand","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040006_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1345\/aph.1G216","article-title":"Systematic review of the effects of ginseng on cardiovascular risk factors","volume":"40","author":"Buettner","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.111.040006_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00280-004-0919-6","article-title":"Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells","volume":"55","author":"Cheng","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.111.040006_bib5","first-page":"1","article-title":"Ginsenosides chemistry, biosynthesis, analysis, and potential health effects","volume":"55","author":"Christensen","year":"2009","journal-title":"Adv Food Nutr Res"},{"key":"10.1124\/dmd.111.040006_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2710.2003.00467.x","article-title":"The effects of Panax ginseng on quality of life","volume":"28","author":"Coleman","year":"2003","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/dmd.111.040006_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.111.040006_bib8","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.fct.2009.06.013","article-title":"Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs","volume":"47","author":"Gu","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1124\/dmd.111.040006_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/00498254.2010.500744","article-title":"Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters","volume":"40","author":"Gu","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.111.040006_bib10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1124\/dmd.110.033845","article-title":"Microsomal cytochrome P450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship","volume":"38","author":"Hao","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040006_bib11","first-page":"259","article-title":"Cancer prevention and therapeutics: Panax ginseng","volume":"9","author":"Helms","year":"2004","journal-title":"Altern Med Rev"},{"key":"10.1124\/dmd.111.040006_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.103.053496","article-title":"Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model","volume":"307","author":"Hu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.111.040006_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/mp0498852","article-title":"Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models","volume":"2","author":"Jeong","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.111.040006_bib14","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.2174\/092986709788803204","article-title":"Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine","volume":"16","author":"Jia","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1124\/dmd.111.040006_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-003-0720-y","article-title":"The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice","volume":"53","author":"Kemper","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.111.040006_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-3659(01)00480-1","article-title":"Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney","volume":"78","author":"Kusuhara","year":"2002","journal-title":"J Control Release"},{"key":"10.1124\/dmd.111.040006_bib17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1124\/dmd.109.029819","article-title":"Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040006_bib18","first-page":"3379","article-title":"Co-administration of cyclosporine enables oral therapy with paclitaxel","volume":"5","author":"Meerum Terwogt","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.111.040006_bib19","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/rcm.2232","article-title":"Liquid chromatography\/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2","volume":"19","author":"Qian","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.111.040006_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.111.040006_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bdd.650","article-title":"Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells","volume":"30","author":"Shirasaka","year":"2009","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.111.040006_bib22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/dmd.105.005421","article-title":"Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity","volume":"33","author":"Taub","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.040006_bib23","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1158\/0008-5472.CAN-09-2915","article-title":"Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity","volume":"69","author":"van Waterschoot","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.111.040006_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ptr.2786","article-title":"Chemopreventive effect of Panax ginseng","volume":"23","author":"Varjas","year":"2009","journal-title":"Phytother Res"},{"key":"10.1124\/dmd.111.040006_bib25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-3565(24)39142-6","article-title":"Efflux of dietary flavonoid quercetin 4\u2032-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2","volume":"294","author":"Walgren","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.111.040006_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1742-7843.2006.pto_348.x","article-title":"Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide","volume":"98","author":"Wang","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.111.040006_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1248\/bpb.28.383","article-title":"Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells","volume":"28","author":"Xie","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.111.040006_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1022254617664","article-title":"Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo","volume":"20","author":"Xu","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.111.040006_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1593\/neo.07160","article-title":"Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A\/J mice","volume":"9","author":"Yan","year":"2007","journal-title":"Neoplasia"},{"key":"10.1124\/dmd.111.040006_bib30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jpba.2009.11.020","article-title":"Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS\/MS method","volume":"51","author":"Yang","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.111.040006_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpba.2010.03.011","article-title":"Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS\/MS method: application to an oral bioavailability study of genistein in mice","volume":"53","author":"Yang","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.111.040006_bib32","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1111\/j.1753-4887.1996.tb03822.x","article-title":"Experimental and epidemiological evidence of the cancer-preventive effects of Panax ginseng C.A. Meyer","volume":"54","author":"Yun","year":"1996","journal-title":"Nutr Rev"},{"key":"10.1124\/dmd.111.040006_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0027-5107(02)00322-6","article-title":"Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds","volume":"523\u2013524","author":"Yun","year":"2003","journal-title":"Mutat Res"},{"key":"10.1124\/dmd.111.040006_bib34","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1124\/dmd.110.034793","article-title":"20(S)-Ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions","volume":"38","author":"Zhang","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.040006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:01:18Z","timestamp":1739908878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624224946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0090955624224946"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.040006","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.040006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}